By Matthew Perlman ( September 1, 2021, 7:49 PM EDT) -- The Federal Trade Commission remained busy last month, pushing ahead with several merger challenges both in federal court and in administrative proceedings, including its closely watched bid to block Illumina's $8 billion purchase of cancer detection company Grail, while enforcers from the U.S., Europe and the U.K. all advanced major investigations....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.